<DOC>
	<DOC>NCT01370044</DOC>
	<brief_summary>The aim of this clinical trail is to evaluate the efficacy of a Carbogen inhalation in patients with febrile seizures compared to a placebo-inhalation. Further aims are the evaluation of the safety of the Carbogen inhalation via a low-pressure can with a breathing mask in a home-setting, the manageability of the Carbogen inhalation via a low pressure can with a breathing mask in a home-setting or on the way (mobility), the quality of life of the parents and children using the low pressure can with a breathing mask in a home-setting or on the way (mobility) and the contentment and anxiety of the parents.</brief_summary>
	<brief_title>Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Seizures, Febrile</mesh_term>
	<criteria>condition after febrile seizure age 12 months to 5 years written informed consent severe other organic disease meningitis as possible cause for the cerebral seizure neurologic disease or cerebral dysplasia cerebrale seizures without fever in the medical history hypersynchronic eeg activity disorder of the respiratory tract (Asthma e.g.)</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Febrile Seizure</keyword>
	<keyword>Carbon Dioxide</keyword>
	<keyword>Carbogen</keyword>
	<keyword>Respiratory Alkalosis</keyword>
</DOC>